This underscores the importance of continued healthy habits and possibly ongoing treatment to sustain weight loss benefits
Oral semaglutide uses an absorption enhancer to survive the stomach and get absorbed in the small intestine, while the injectable form bypasses the digestive system entirely
Last year Pfizer won a bidding war with Novo Nordisk for a small obesity drug developer, Metsera, in a deal valued at $10 billion
it is not medical advice, and off-label use should be undertaken only under qualified medical supervision
Common adverse effects include diarrhoea, abdominal cramping and nausea, particularly with magnesium oxide or citrate formulations
That means avoiding: Mega doses Harsh forms Needle based stacking unless supervised Gentle, consistent support usually wins here